Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Autolus Therapeutics stock

Learn how to easily invest in Autolus Therapeutics stock.

Autolus Therapeutics plc is a biotechnology business based in the US. Autolus Therapeutics shares (AUTL) are listed on the NASDAQ and all prices are listed in US Dollars. Autolus Therapeutics employs 376 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Autolus Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AUTL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Autolus Therapeutics stock price (NASDAQ: AUTL)

Use our graph to track the performance of AUTL stocks over time.

Autolus Therapeutics shares at a glance

Information last updated 2022-01-11.
Latest market close$4.41
52-week range$4.44 - $9.40
50-day moving average $5.91
200-day moving average $6.14
Wall St. target price$15.06
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.22

Buy Autolus Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Autolus Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Autolus Therapeutics price performance over time

Historical closes compared with the close of $4.41 from 2022-01-14

1 week (2022-01-07) -5.16%
1 month (2021-12-17) -18.93%
3 months (2021-10-15) -28.18%
6 months (2021-07-17) -34.38%
1 year (2021-01-15) -51.11%
2 years (2020-01-16) -65.68%
3 years (2019-01-16) 30.87
5 years (2017-01-13) N/A

Autolus Therapeutics financials

Revenue TTM $2.6 million
Gross profit TTM $-133,173,000
Return on assets TTM -33.53%
Return on equity TTM -59.51%
Profit margin 0%
Book value $3.36
Market capitalisation $342 million

TTM: trailing 12 months

Autolus Therapeutics share dividends

We're not expecting Autolus Therapeutics to pay a dividend over the next 12 months.

Autolus Therapeutics share price volatility

Over the last 12 months, Autolus Therapeutics's shares have ranged in value from as little as $4.44 up to $9.4. A popular way to gauge a stock's volatility is its "beta".

AUTL.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Autolus Therapeutics's is 1.4506. This would suggest that Autolus Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Autolus Therapeutics overview

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; AUTO3NG for the treatment of hematological cancer; AUTO4 and AUTO5 for T cell lymphoma; AUTO6NG for the treatment of programmed T cell therapies; AUTO6 for the treatment of neuroblastoma; and AUTO7 for the treatment of prostate cancer. Autolus Therapeutics plc was founded in 2014 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of Autolus Therapeutics is owned by insiders or institutions?
Currently 25.23% of Autolus Therapeutics shares are held by insiders and 59.704% by institutions.
How many people work for Autolus Therapeutics?
Latest data suggests 376 work at Autolus Therapeutics.
When does the fiscal year end for Autolus Therapeutics?
Autolus Therapeutics's fiscal year ends in September.
Where is Autolus Therapeutics based?
Autolus Therapeutics's address is: Forest House, London, United Kingdom, W12 7RZ
What is Autolus Therapeutics's ISIN number?
Autolus Therapeutics's international securities identification number is: US05280R1005
What is Autolus Therapeutics's CUSIP number?
Autolus Therapeutics's Committee on Uniform Securities Identification Procedures number is: 05280R100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site